HomeHome
ProductsProducts
Building BlocksBuilding Blocks
Heterocyclic ScaffoldsHeterocyclic Scaffolds
Aromatic HeterocyclesAromatic Heterocycles
AfoxolanerAfoxolaner

Afoxolaner

In Stock•Starting at $26 for 100 mg•Purity ≥ 98%

CAS No.	1093861-60-9
MDL No.	MFCD30533411
MF	C₂₆H₁₇ClF₉N₃O₃
MW	625.90
InChI Key	OXDDDHGGRFRLEE-UHFFFAOYSA-N

CUSTOM SYNTHESIS PRECLINICAL SUPPORT→

Pricing & Availability

Pack Size	Purity	Price	Availability
100 mg	98%	$26	In Stock
250 mg	98%	$42	In Stock
1 g	98%	$112	In Stock
5 g	98%	$383	In Stock
10 g	98%	$610	In Stock

Product Information

CAS No.	1093861-60-9
Product Name	Afoxolaner

Health Hazard

Environmental Hazard

Signal Word:Warning

HCode:H361-H410

PCode:P203-P273-P280-P318-P391-P405-P501

Studies related to this compound and its mechanism of action

Successful treatment of Ophionyssus natricis with afoxolaner in two Burmese pythons (Python molurus bivittatus).

Veterinary dermatology • Vol. 31, Issue 6 • 2020

PMID: 33016515 DOI: 10.1111/vde.12898

Use of afoxolaner for the treatment of lice (Goniodes pavonis) in different genera (Chrysolophus spp, Lophura spp, Phasianus spp, and Syrmaticus spp) and species of pheasants and West Mexican Chachalacas (Ortalis poliocephala).

Veterinary parasitology • Vol. 280 • 2020

PMID: 32203695 DOI: 10.1016/j.vetpar.2020.109065

Efficacy of afoxolaner in the flea control in experimentally infested cats.

Revista brasileira de parasitologia veterinaria = Brazilian journal of veterinary parasitology : Orgao Oficial do Colegio Brasileiro de Parasitologia Veterinaria • Vol. 28, Issue 4 • 2019

PMID: 31483035 DOI: 10.1590/S1984-29612019064

Evaluation of afoxolaner chewables to control flea populations in naturally infested dogs in private residences in Tampa FL, USA.

Parasites & vectors • Vol. 8 • 2015

PMID: 26003175 PMC: PMC4445572 DOI: 10.1186/s13071-015-0897-z

Similar Products

4-[5-[3-Chloro-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]naphthalene-1-carboxylic acid
CAS No.1308362-48-2

Products
- CDMO Compounds
- API & Candidates
Services
CDMO & Manufacturing
Custom Synthesis
Process Development
Lab To Pilot
Commercialization
Generic APIs
CRO
Preclinical
Pharmacology & Efficacy
DMPK & Bioanalysis
Toxicology & Safety
Disease Models
Technologies
High-Potent
Chiral Synthesis
Cloud Synthesis
Fermentation
Flow Chemistry
Biocatalysis
Support
Regulatory Support
Supply Chain Solutions
About
Perspectives
Contact

HomeHome
ProductsProducts
Building BlocksBuilding Blocks
Heterocyclic ScaffoldsHeterocyclic Scaffolds
Aromatic HeterocyclesAromatic Heterocycles
AfoxolanerAfoxolaner

Afoxolaner

In Stock•Starting at $26 for 100 mg•Purity ≥ 98%

CAS No.	1093861-60-9
MDL No.	MFCD30533411
MF	C₂₆H₁₇ClF₉N₃O₃
MW	625.90
InChI Key	OXDDDHGGRFRLEE-UHFFFAOYSA-N

CUSTOM SYNTHESIS PRECLINICAL SUPPORT→

Pricing & Availability

Pack Size	Purity	Price	Availability
100 mg	98%	$26	In Stock
250 mg	98%	$42	In Stock
1 g	98%	$112	In Stock
5 g	98%	$383	In Stock
10 g	98%	$610	In Stock

Product Information

CAS No.	1093861-60-9
Product Name	Afoxolaner

Health Hazard

Environmental Hazard

Signal Word:Warning

HCode:H361-H410

PCode:P203-P273-P280-P318-P391-P405-P501

Studies related to this compound and its mechanism of action

Successful treatment of Ophionyssus natricis with afoxolaner in two Burmese pythons (Python molurus bivittatus).

Veterinary dermatology • Vol. 31, Issue 6 • 2020

PMID: 33016515 DOI: 10.1111/vde.12898

Use of afoxolaner for the treatment of lice (Goniodes pavonis) in different genera (Chrysolophus spp, Lophura spp, Phasianus spp, and Syrmaticus spp) and species of pheasants and West Mexican Chachalacas (Ortalis poliocephala).

Veterinary parasitology • Vol. 280 • 2020

PMID: 32203695 DOI: 10.1016/j.vetpar.2020.109065

Efficacy of afoxolaner in the flea control in experimentally infested cats.

Revista brasileira de parasitologia veterinaria = Brazilian journal of veterinary parasitology : Orgao Oficial do Colegio Brasileiro de Parasitologia Veterinaria • Vol. 28, Issue 4 • 2019

PMID: 31483035 DOI: 10.1590/S1984-29612019064

Evaluation of afoxolaner chewables to control flea populations in naturally infested dogs in private residences in Tampa FL, USA.

Parasites & vectors • Vol. 8 • 2015

PMID: 26003175 PMC: PMC4445572 DOI: 10.1186/s13071-015-0897-z

Similar Products

4-[5-[3-Chloro-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]naphthalene-1-carboxylic acid
CAS No.1308362-48-2

Your Partner for
Complex Chemistry

About Us
Perspectives
Products
Contact

Preclinical Development
Technologies
Custom Synthesis

Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT

Westerstraat 10, 3016 DH, Rotterdam, The Netherlands

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|

Afoxolaner

Pricing & Availability

Product Information

Safety Information

Properties

Afoxolaner

Pricing & Availability

Product Information

Safety Information

Properties

Documentation

Afoxolaner

Pricing & Availability

Product Information

Safety Information

Properties

Related Articles

Successful treatment of Ophionyssus natricis with afoxolaner in two Burmese pythons (Python molurus bivittatus).

Use of afoxolaner for the treatment of lice (Goniodes pavonis) in different genera (Chrysolophus spp, Lophura spp, Phasianus spp, and Syrmaticus spp) and species of pheasants and West Mexican Chachalacas (Ortalis poliocephala).

Efficacy of afoxolaner in the flea control in experimentally infested cats.

Evaluation of afoxolaner chewables to control flea populations in naturally infested dogs in private residences in Tampa FL, USA.

Similar Products

4-[5-[3-Chloro-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]naphthalene-1-carboxylic acid

Afoxolaner

Pricing & Availability

Product Information

Safety Information

Properties

Related Articles

Successful treatment of Ophionyssus natricis with afoxolaner in two Burmese pythons (Python molurus bivittatus).

Use of afoxolaner for the treatment of lice (Goniodes pavonis) in different genera (Chrysolophus spp, Lophura spp, Phasianus spp, and Syrmaticus spp) and species of pheasants and West Mexican Chachalacas (Ortalis poliocephala).

Efficacy of afoxolaner in the flea control in experimentally infested cats.

Evaluation of afoxolaner chewables to control flea populations in naturally infested dogs in private residences in Tampa FL, USA.

Similar Products

4-[5-[3-Chloro-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]naphthalene-1-carboxylic acid

Documentation